Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06SBD
|
|||
| Former ID |
DNCL002465
|
|||
| Drug Name |
DS-2248
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Daiichi Sankyo
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H12N2O2
|
|||
| Canonical SMILES |
CC(C)C1=C(C=C(C=C1)[N+](=O)[O-])N
|
|||
| InChI |
1S/C9H12N2O2/c1-6(2)8-4-3-7(11(12)13)5-9(8)10/h3-6H,10H2,1-2H3
|
|||
| InChIKey |
VKEVGYZHNPSPOF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 132475-93-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01288430) A Study of DS-2248, in Subjects With Advanced Solid Tumors. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.